• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of during epithelial-mesenchymal transition.

作者信息

Baranwal Somesh

机构信息

Center for Biochemistry and Microbial Science, School of Basic and Applied Science, Central University of Punjab, Bathinda, India.

出版信息

Front Cell Dev Biol. 2017 Oct 16;5:91. doi: 10.3389/fcell.2017.00091. eCollection 2017.

DOI:10.3389/fcell.2017.00091
PMID:29085822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5650611/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5794/5650611/00c20a027d33/fcell-05-00091-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5794/5650611/00c20a027d33/fcell-05-00091-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5794/5650611/00c20a027d33/fcell-05-00091-g0001.jpg

相似文献

1
Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of during epithelial-mesenchymal transition.评论：HNRNPLL，一种新发现的结直肠癌转移抑制因子，在上皮-间质转化过程中调节……的可变剪接。 （原文此处“of”后面内容缺失）
Front Cell Dev Biol. 2017 Oct 16;5:91. doi: 10.3389/fcell.2017.00091. eCollection 2017.
2
HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of during epithelial-mesenchymal transition.HNRNPLL，一种新鉴定的结直肠癌转移抑制因子，调节上皮-间充质转化过程中 的可变剪接。
Gut. 2018 Jun;67(6):1103-1111. doi: 10.1136/gutjnl-2016-312927. Epub 2017 Mar 30.
3
Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.癌症相关的 MORC2 突变 M276I 通过调控 hnRNPM 介导的 CD44 剪接开关促进三阴性乳腺癌的侵袭和转移。
Cancer Res. 2018 Oct 15;78(20):5780-5792. doi: 10.1158/0008-5472.CAN-17-1394. Epub 2018 Aug 9.
4
Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.可变剪接的CD44可区分上皮性前列腺癌细胞与其间充质对应细胞。
Med Oncol. 2015 May;32(5):159. doi: 10.1007/s12032-015-0593-z. Epub 2015 Apr 9.
5
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.CD44变体6与晚期上皮性卵巢癌患者的腹膜播散及不良预后相关。
Cancer Sci. 2015 Oct;106(10):1421-8. doi: 10.1111/cas.12765. Epub 2015 Sep 21.
6
Regulation of alternative splicing of CD44 in cancer.癌症中CD44可变剪接的调控
Cell Signal. 2014 Oct;26(10):2234-9. doi: 10.1016/j.cellsig.2014.07.011. Epub 2014 Jul 13.
7
Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.上皮-间质转化可能通过结直肠癌中CD44异构体的转换而被诱导。
J Surg Oncol. 2014 Nov;110(6):745-51. doi: 10.1002/jso.23705. Epub 2014 Jun 29.
8
Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition.敲低CD44可通过逆转上皮-间质转化来抑制肝癌在体外和体内的侵袭与转移。
Oncotarget. 2015 Apr 10;6(10):7828-37. doi: 10.18632/oncotarget.3488.
9
CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.CD82 通过介导 U2AF2 泛素化和降解来抑制 CD44 可变剪接依赖性黑色素瘤转移。
Oncogene. 2016 Sep 22;35(38):5056-5069. doi: 10.1038/onc.2016.67. Epub 2016 Apr 4.
10
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.癌症干细胞标志物（Notch1、醛脱氢酶1和CD44）在原发性结直肠癌中的预后价值
J Gastrointest Cancer. 2019 Dec;50(4):824-837. doi: 10.1007/s12029-018-0156-6.

引用本文的文献

1
Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification.与胶质瘤预后和免疫浸润相关的可变剪接事件的全景分析：数据分析和基础验证。
J Immunol Res. 2022 Jul 4;2022:2671891. doi: 10.1155/2022/2671891. eCollection 2022.
2
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.与结直肠癌发生和预后相关的可变剪接事件。
J Cancer. 2018 Apr 19;9(10):1754-1764. doi: 10.7150/jca.24569. eCollection 2018.

本文引用的文献

1
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.上皮-间质转化、癌症干细胞与耐药性：机制联系及临床意义
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629. doi: 10.1038/nrclinonc.2017.44. Epub 2017 Apr 11.
2
HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of during epithelial-mesenchymal transition.HNRNPLL，一种新鉴定的结直肠癌转移抑制因子，调节上皮-间充质转化过程中 的可变剪接。
Gut. 2018 Jun;67(6):1103-1111. doi: 10.1136/gutjnl-2016-312927. Epub 2017 Mar 30.
3
Emerging Biological Principles of Metastasis.
转移的新兴生物学原理
Cell. 2017 Feb 9;168(4):670-691. doi: 10.1016/j.cell.2016.11.037.
4
An evidence-based knowledgebase of metastasis suppressors to identify key pathways relevant to cancer metastasis.一个基于证据的转移抑制因子知识库，用于识别与癌症转移相关的关键途径。
Sci Rep. 2015 Oct 21;5:15478. doi: 10.1038/srep15478.
5
Proteomics. Tissue-based map of the human proteome.蛋白质组学。人类蛋白质组组织图谱。
Science. 2015 Jan 23;347(6220):1260419. doi: 10.1126/science.1260419.
6
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.一项针对人类结肠癌转移抑制因子的新型全基因组体内筛选鉴定出正向WNT-TCF信号通路调节因子TMED3和SOX12。
EMBO Mol Med. 2014 Jul;6(7):882-901. doi: 10.15252/emmm.201303799.
7
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.CD44v6 是驱动结肠癌转移的组成性和重编程癌症干细胞的标志物。
Cell Stem Cell. 2014 Mar 6;14(3):342-56. doi: 10.1016/j.stem.2014.01.009.
8
Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).在上皮-间充质转化（EMT）过程中做出可变剪接决策。
Cell Mol Life Sci. 2012 Aug;69(15):2515-26. doi: 10.1007/s00018-012-0931-7. Epub 2012 Feb 19.
9
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer.KLF17是乳腺癌上皮-间质转化和转移的负调控因子。
Nat Cell Biol. 2009 Nov;11(11):1297-304. doi: 10.1038/ncb1974. Epub 2009 Oct 4.
10
Learning therapeutic lessons from metastasis suppressor proteins.从转移抑制蛋白中汲取治疗经验。
Nat Rev Cancer. 2009 Apr;9(4):253-64. doi: 10.1038/nrc2594. Epub 2009 Feb 26.